- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Board

The WEHI board governs the Institute, manages policy and provides strategic direction.
Key documents
- Constitution of the Walter and Eliza Hall Institute of Medical Research
- approved unanimously at the AGM on 19 May 2022 - Corporate Governance Manual
Mrs Jane Hemstritch AO
BSc (Hons) London University FICAEW FAICD Mrs Hemstritch was managing director Asia Pacific for Accenture Limited from 2004 until her retirement in February 2007. In this role, Mrs Hemstritch was a member of Accenture’s global executive leadership team and oversaw the management of Accenture’s business portfolio in Asia Pacific. She holds a Bachelor of Science with Honours in biochemistry and physiology and has professional expertise in technology, communications, change management and accounting. Mrs Hemstritch is a member of the Global Council of Herbert Smith Freehills, the Council of Governing Members of The Smith Family and Chief Executive Women. She is a former non-executive director of Lend Lease Corporation Limited and is Chair of the Accenture Australia Foundation. |
|
Professor Sir John Savill
BA Oxford MBChB Sheffield PhD London FRCP FRCPE FRCSEd (Hon) FRCPCH(Hon) FASN FRSE FMedSci FRS Professor Sir John is the executive director of the Melbourne Academic Centre for Health (July 2019-present) after having served as an honorary consultant in renal and acute medicine in the UK (1990-2018). In 2000 he established the Medical Research Council (MRC) Centre for Inflammation Research in Edinburgh as inaugural director. Professor Sir John served as Vice-Principal and Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh (2002-17) and was appointed to the Regius Chair of Medical Science in 2017. He was Chief Scientist in the Scottish Government Health Directorates (2008-10) and Chief Executive of the UK Medical Research Council (2010-18), having previously served as a member of MRC Council and research board chair (2002-08). Professor Sir John’s work has been recognised by fellowships of the Royal Colleges of Physicians of London and Edinburgh, the Academy of Medical Sciences, the American Society of Nephrology, The Royal Society of Edinburgh, The Royal Society and honorary fellowships from the Royal College of Surgeons of Edinburgh and the Royal College of Paediatrics and Child Health. He was knighted in the 2008 New Year’s Honours List for services to clinical science. |
|
Mr Malcolm Broomhead AO
BE (Civil) MBA UQ FIE (Aus) FAusIMM FAIM MICE (UK), FAICD Mr Broomhead is a professional non-executive director. His directorships include Orica Limited (Chairman) and he is a council member of Opportunity International Australia. He is a former director of BHP Group Limited & Plc. Mr Broomhead was formerly managing director and CEO of Orica Limited from 2001 until September 2005. Prior to Orica, he was Managing Director and CEO of the global diversified resources company North Limited. He has had extensive experience in the resources industry, as well as in finance, investment and construction activities. He has worked in management positions with Halcrow (UK), MIM Holdings, Peko Wallsend and Industrial Equity. |
|
Associate Professor (Practice) Pippa Connolly
MEng Leeds GAICD CPEng FIEAust Associate Professor Pippa Connolly is a non-executive director at the Royal Melbourne Hospital. Her previous board experience includes positions with the State Board of Arup and the National Association of Women in Construction. Associate Professor Connolly has a background as a senior executive building engineer, delivering multiple-disciplinary major infrastructure projects including the National Museum of Australia, the Museum of New Zealand Te Papa Tongarewa (Te Papa), Olympic Dam infrastructure and the expansion of the Walter and Eliza Hall Institute. Much of her experience has been gained as a director/principal of Arup in the UK, USA, Singapore, New Zealand and Australia. She holds a Masters in Architectural Engineering and is an Associate Professor at Monash University where she lectures and coordinates the Capstone Unit in Civil and Environmental Engineering practice and mentors two industry intern programs for Monash University. |
|
Mr John Dyson
BSc Monash Grad Dip Fin Inv SIA MBA RMIT Mr Dyson has been an active participant in the venture capital industry for two decades. He is one of the founders of Starfish Ventures, a venture capital company established in 2001; and former chair of Swinburne Ventures Pty Ltd, the entity responsible for the commercialisation of technology for Swinburne University of Technology. From 1997 to 2002 he was a director of the Australian Venture Capital Association Limited, including Deputy Chairman in 1998 and Chairman in 1999. He is currently a director of technology companies Aktana, Atmail, Audinate, Design Crowd, Echoview, Hearables 3D and Nitro Software. Mr Dyson is a former Chairman of the Mount Buller and Mount Stirling Alpine Resort Management Board, which oversees the management of Victoria’s largest alpine resort. He is also a co-trustee of the Dyson Bequest, a $15 million charitable foundation that supports a range of social welfare, education, medical research and environmental causes. |
|
Professor Jane Gunn
MBBS PhD Melbourne FAHMS FRACGP DRANZCOG Professor Gunn is a distinguished clinician scientist with extensive experience in primary care research as well as hospital and not-for-profit governance. Since 2018 she has held the position of Deputy Dean in the Faculty of Medicine, Dentistry and Health Sciences (MDHS) at the University of Melbourne, and in February 2021 commenced as Dean. Professor Gunn has played key leadership roles in reforming healthcare, beginning with her work in shared maternity care and cervical screening programs, and more recently in transforming mental health care in primary care settings. Her research and leadership experience led to a Ministerial Appointment to the NHMRC Research Committee (2009-2015) where she Chaired a variety of grant review and fellowship committees. Professor Gunn is a past Board member of the Peter MacCallum Cancer Centre and a current Board Director of Melbourne Health, The Florey Institute of Neuroscience and Mental Health, The Murdoch Children’s Research Institute, The Melbourne Academic Centre for Health, The Eastern Melbourne Primary Health Network and of Dental Health Services Victoria. |
|
Professor Christine Kilpatrick AO
MBBS MBA MD DMedSci (Hons) Melbourne FRACP FRACMA FAICD FAHMS Professor Kilpatrick commenced as Chief Executive, Melbourne Health in May 2017. Previous appointments include Chief Executive, the Royal Children’s Hospital (2008-17), executive director medical services, Melbourne Health and executive director Royal Melbourne Hospital, Melbourne Health (2004-08). Prior to these appointments she was a neurologist, specialising in epilepsy. Professor Kilpatrick is a member of boards including Orygen, National Centre of Excellence in Youth Mental Health, and the Victorian Comprehensive Cancer Centre. She was awarded a Centenary Medal in 2003, in 2014 was included in the Victorian Honour Roll of Women, in 2017 was a recipient of the inaugural Distinguished Fellow’s Award, Royal Australasian College of Medical Administrators, in 2018 was inducted in the Top 50 Public Sector Women and in 2019 appointed an Officer of the Order of Australia. |
|
Professor Duncan MaskellM\A, PhD, FMedSci, Hon Assoc RCVS Professor Duncan Maskell has been Vice-Chancellor of the University of Melbourne since October 2018. Since August 2021, he has also been a non-executive Director of CSL Limited, a major ASX-listed global company. Professor Maskell’s academic career is centred on leading a large research group studying infectious bacterial diseases of people and livestock. He has co-founded four biotech companies, and has been a member of a range of Institute and company Scientific Advisory Boards, and of Government and International research grant and review committees in the United Kingdom. Vice-Chancellor Maskell promotes a strong international presence for the University of Melbourne. He believes strongly in public education for the public good, that universities should play a leading role in public discussion and debate, and that they must be places that celebrate diversity. Prior to becoming Vice-Chancellor in 2018, Professor Maskell held senior leadership roles at the University of Cambridge. |
|
Ms Marie McDonald
BSc (Hons) LLB (Hons) Melbourne Ms McDonald was a partner of Blake Dawson (now global law firm Ashurst) from 1990 to 2014. She specialised in corporate and commercial law and, in particular, cross-border mergers and acquisitions and corporate governance. She was a member of the Australian Takeovers Panel (2001-2010) and Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia (2012, 2013) and a Deputy Chair (2010, 2011). Prior to becoming a lawyer, Ms McDonald completed a Bachelor of Science (Honours) degree with first class honours, majoring in chemistry. Ms McDonald is a non-executive director of CSL Limited, Nanosonics Limited and Nufarm Limited. |
|
Mr Geoff Roberts
BComm Melbourne FCA FAICD Exec MBA AGSM Mr Geoff Roberts has more than 35 years’ finance experience, including as Group Chief Financial Officer of Seek Limited, Managing Partner of Deloitte Victoria, and as Group Chief Financial Officer of AXA Asia Pacific for seven years. He was appointed to the Melbourne Cricket Club Committee in March 2019 and was formerly a Director of AMP Limited. Mr Roberts holds an Executive MBA from the Australian Graduate School of Management and is a Fellow of both the Institute of Chartered Accountants and the Australian Institute of Company Directors. |
|
Ms Carolyn Viney
LLB/BA Monash Ms Carolyn Viney has more than 20 years’ experience in construction, property development and real estate investment. Ms Viney is currently Chief Executive Officer at Super Housing Partnerships, a specialist fund manager focussed on increasing the at scale supply of BTR residential housing, especially affordable housing. Ms Viney is Chair of the advisory board to the Victorian Government’s Office of Projects Victoria, an advisory board member of Women’s Property Initiatives, a not-for-profit housing provider to women and children at risk of homelessness. She is a non-executive director of The Big Issue and Homes for Homes, both of which are not-for-profit providers of employment and support to homeless, marginalised and disadvantaged people. Ms Viney is a former president of the Victorian Division of the Property Council of Australia. |
|
Dr Angeli Weller
BA(Hons) Mount Holyoke MBA Cambridge PhD Copenhagen Business School Dr Angeli Weller has more than two decades of experience as a business ethics and ESG strategist and researcher. |
|
Mr Kee Wong
BE (Hons) Grad Dip Computing MBA FAICD Mr Wong is an entrepreneur with interests in start-ups and established businesses across the technology, retail, property, services, and food and beverage industries in Australia and overseas. He has started several business including being the founder of e-Centric Innovations, a technology consulting firm that operates in Australia, Malaysia and Singapore, serving large multinational enterprises and governments. Mr Wong is a current Board member for a number of corporate and not-for-profit organisations including the ASX100 listed company Carsales.com, the Australian Energy Market Operator (AEMO), the Australian Institute of Company Directors (AICD), the Arts Centre Melbourne, and the Committee for Melbourne. He is also a member of numerous government and academic advisory bodies including the Victorian Government’s Ministerial Advisory Council on International Education and Ministerial Innovation Taskforce, the ANU Centre for Asian-Australian Leadership Advisory Board and Swinburne University’s Technology and Innovation Committee. |